Avastin (bevacizumab)
AVASTIN (bevacizumab) – a vascular endothelial growth factor-specific angiogenesis inhibitor commonly used to treat certain cancers. Bevacizumab binds VEGF and prevents the interaction of VEGF to its receptors (Flt-1 and KDR) on the surface of endothelial cells. The interaction of VEGF with its receptors leads to endothelial cell proliferation and new blood vessel formation in […]